When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. FDA-approved nasal spray for severe depression can lead to ...

   www.aol.com/fda-approved-nasal-spray-severe...

   The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in people who have not responded to at least two oral antidepressants.

3. List of antidepressants - Wikipedia

   en.wikipedia.org/wiki/List_of_antidepressants

   This is a complete list of clinically approved prescription antidepressants throughout the world, as well as clinically approved prescription drugs used to augment antidepressants or mood stabilizers, by pharmacological and/or structural classification.

4. FDA approves Johnson & Johnson’s ketamine-derived ... - AOL

   www.aol.com/finance/fda-approves-johnson-johnson...

   Oral antidepressants, developed in the 1950s and currently one of the most frequently prescribed medications in the U.S., fall into several classes; they include selective serotonin reuptake ...

5. Breakthrough antidepressants with fewer side effects could ...

   www.aol.com/finance/breakthrough-antidepressants...

   The number of people with depression has reached new highs—and so has antidepressant use. ... Wellbutrin (bupropion)—the only FDA-approved NDRI (norepinephrine and dopamine reuptake inhibitor ...

6. List of investigational antidepressants - Wikipedia

   en.wikipedia.org/wiki/List_of_investigational...

   This is a list of investigational antidepressants, or drugs that are currently under development for clinical use in the treatment of depression but are not yet approved. Specific indications include major depressive disorder , treatment-resistant depression , dysthymia , bipolar depression , and postpartum depression , among others.

7. Selective serotonin reuptake inhibitor - Wikipedia

   en.wikipedia.org/wiki/Selective_serotonin...

   A 2006 review suggests that the widespread use of antidepressants in the new "SSRI-era" appears to have led to a highly significant decline in suicide rates in most countries with traditionally high baseline suicide rates. The decline is particularly striking for women who, compared with men, seek more help for depression.